Document is current
Any future updates will be listed below
-
Authors
Salimi, Yasamin
Domingo-Fernández, Daniel
Bobis-Álvarez, Carlos
Hofmann-Apitius, Martin
Birkenbihl, Colin
,
-
Funding
Funding for this research was provided by:
European Union’s Horizon 2020 (826421)
European Union’s Horizon 2020 (826421)
European Union’s Horizon 2020 (826421)
Innovative Medicines Initiative Joint Undertaking (117536)
Innovative Medicines Initiative Joint Undertaking (117536)
Innovative Medicines Initiative Joint Undertaking (117536)
Fraunhofer-Institut für Algorithmen und Wissenschaftliches Rechnen SCAI
- License Information
-
More Information
Article History
Received: 26 November 2021
Accepted: 27 April 2022
First Online: 21 May 2022
Declarations
:
: All investigated studies acquired informed consent for data collection and sharing from their participants. All cohort studies got ethical approval. For more details, we refer to their individual references.
: The publication guidelines of each individual cohort study were followed and the manuscript was submitted and subsequently approved by all data owners that requested manuscript clearing.
: DDF received a salary from Enveda Biosciences, and the company has no competing interests with the published results. The rest of the authors declare that they have no competing interests.
